Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma

Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.
Latest website image capture
Clouds background image

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical-trial page displays the study record for SL-701 in recurrent glioblastoma, including its design, eligibility criteria, treatment arms, outcomes, and linked documents.
    Difference
    69%
    Check dated 2026-11-07T13:19:10.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:18:16.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a website transition and says agencies are using “Super Intelligence” instead of “Artificial Intelligence.” It appears above the inaccessible study record.
    Difference
    1%
    Check dated 2026-10-24T18:15:49.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision identifier advanced from v3.7.1 to v3.7.2, while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T20:20:48.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0 on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-10T20:39:46.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error view instead of the study content, indicating the record is inaccessible. The page shows the 403 banner along with a Home link and site footer, signaling that the record cannot be accessed at this time.
    Difference
    21%
    Check dated 2026-09-19T20:50:19.000Z thumbnail image

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma

Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.